Thermo Fisher Scientific EBITDA Margin 2012-2025 | TMO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current EBITDA margin for Thermo Fisher Scientific as of December 31, 2025 is .
| Thermo Fisher Scientific EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $43.74B | $10.30B | 23.56% |
| 2025-06-30 | $43.21B | $10.28B | 23.79% |
| 2025-03-31 | $42.90B | $10.37B | 24.17% |
| 2024-12-31 | $42.88B | $10.45B | 24.36% |
| 2024-09-30 | $42.37B | $10.38B | 24.50% |
| 2024-06-30 | $42.35B | $10.52B | 24.84% |
| 2024-03-31 | $42.49B | $10.34B | 24.34% |
| 2023-12-31 | $42.86B | $10.27B | 23.95% |
| 2023-09-30 | $43.42B | $10.28B | 23.68% |
| 2023-06-30 | $43.52B | $10.11B | 23.23% |
| 2023-03-31 | $43.81B | $10.52B | 24.01% |
| 2022-12-31 | $44.92B | $11.77B | 26.21% |
| 2022-09-30 | $44.17B | $12.29B | 27.82% |
| 2022-06-30 | $42.82B | $12.64B | 29.53% |
| 2022-03-31 | $41.12B | $12.63B | 30.71% |
| 2021-12-31 | $39.21B | $12.62B | 32.18% |
| 2021-09-30 | $39.06B | $13.07B | 33.47% |
| 2021-06-30 | $38.25B | $13.17B | 34.42% |
| 2021-03-31 | $35.89B | $12.31B | 34.29% |
| 2020-12-31 | $32.22B | $10.12B | 31.41% |
| 2020-09-30 | $28.50B | $8.25B | 28.96% |
| 2020-06-30 | $26.25B | $6.77B | 25.81% |
| 2020-03-31 | $25.65B | $6.88B | 26.81% |
| 2019-12-31 | $25.54B | $6.87B | 26.90% |
| 2019-09-30 | $25.22B | $6.77B | 26.84% |
| 2019-06-30 | $24.87B | $6.72B | 27.03% |
| 2019-03-31 | $24.63B | $6.16B | 25.03% |
| 2018-12-31 | $24.36B | $6.05B | 24.84% |
| 2018-09-30 | $23.90B | $5.88B | 24.58% |
| 2018-06-30 | $23.09B | $5.55B | 24.04% |
| 2018-03-31 | $22.01B | $5.27B | 23.94% |
| 2017-12-31 | $20.92B | $4.99B | 23.87% |
| 2017-09-30 | $19.82B | $4.70B | 23.69% |
| 2017-06-30 | $19.20B | $4.52B | 23.54% |
| 2017-03-31 | $18.74B | $4.37B | 23.30% |
| 2016-12-31 | $18.27B | $4.22B | 23.07% |
| 2016-09-30 | $17.97B | $4.10B | 22.78% |
| 2016-06-30 | $17.61B | $4.11B | 23.36% |
| 2016-03-31 | $17.34B | $4.06B | 23.38% |
| 2015-12-31 | $16.97B | $4.03B | 23.73% |
| 2015-09-30 | $16.81B | $3.98B | 23.68% |
| 2015-06-30 | $16.85B | $4.08B | 24.23% |
| 2015-03-31 | $16.91B | $3.85B | 22.78% |
| 2014-12-31 | $16.89B | $4.19B | 24.80% |
| 2014-09-30 | $15.86B | $3.82B | 24.10% |
| 2014-06-30 | $14.89B | $3.37B | 22.65% |
| 2014-03-31 | $13.80B | $3.21B | 23.28% |
| 2013-12-31 | $13.09B | $2.61B | 19.94% |
| 2013-09-30 | $12.88B | $2.56B | 19.88% |
| 2013-06-30 | $12.78B | $2.52B | 19.68% |
| 2013-03-31 | $12.65B | $2.50B | 19.76% |
| 2012-12-31 | $12.51B | $2.47B | 19.70% |
| 2012-09-30 | $12.30B | $2.40B | 19.54% |
| 2012-06-30 | $12.15B | $2.35B | 19.36% |
| 2012-03-31 | $11.90B | $2.21B | 18.57% |
| 2011-12-31 | $11.56B | $2.11B | 18.26% |
| 2011-09-30 | $11.05B | $2.00B | 18.08% |
| 2011-06-30 | $10.75B | $1.94B | 18.03% |
| 2011-03-31 | $10.49B | $1.96B | 18.64% |
| 2010-12-31 | $10.39B | $1.93B | 18.54% |
| 2010-09-30 | $10.49B | $1.91B | 18.16% |
| 2010-06-30 | $10.40B | $1.89B | 18.20% |
| 2010-03-31 | $10.28B | $1.86B | 18.11% |
| 2009-12-31 | $9.91B | $1.76B | 17.80% |
| 2009-09-30 | $9.92B | $1.82B | 18.36% |
| 2009-06-30 | $9.97B | $1.84B | 18.41% |
| 2009-03-31 | $10.20B | $1.91B | 18.76% |
| 2008-12-31 | $10.50B | $2.02B | 19.26% |
| 2008-09-30 | $10.47B | $1.99B | 18.97% |
| 2008-06-30 | $10.29B | $1.94B | 18.89% |
| 2008-03-31 | $9.96B | $1.84B | 18.50% |
| 2007-12-31 | $9.75B | $1.73B | 17.77% |
| 2007-09-30 | $8.79B | $1.40B | 15.93% |
| 2007-06-30 | $7.12B | $1.07B | 15.09% |
| 2007-03-31 | $5.45B | $0.76B | 13.86% |
| 2006-12-31 | $3.79B | $0.48B | 12.71% |
| 2006-09-30 | $2.86B | $0.46B | 15.96% |
| 2006-06-30 | $2.82B | $0.44B | 15.68% |
| 2006-03-31 | $2.76B | $0.41B | 15.01% |
| 2005-12-31 | $2.63B | $0.39B | 14.66% |
| 2005-09-30 | $2.51B | $0.35B | 13.77% |
| 2005-06-30 | $2.37B | $0.32B | 13.56% |
| 2005-03-31 | $2.24B | $0.31B | 13.98% |
| 2004-12-31 | $2.21B | $0.30B | 13.79% |
| 2004-09-30 | $2.08B | $0.29B | 13.83% |
| 2004-06-30 | $1.98B | $0.26B | 13.32% |
| 2004-03-31 | $1.92B | $0.25B | 12.89% |
| 2003-12-31 | $1.90B | $0.23B | 12.27% |
| 2003-09-30 | $1.75B | $0.22B | 12.53% |
| 2003-06-30 | $1.82B | $0.23B | 12.39% |
| 2003-03-31 | $1.86B | $0.22B | 11.57% |
| 2002-12-31 | $1.85B | $0.21B | 11.52% |
| 2002-09-30 | $2.08B | $0.14B | 6.50% |
| 2002-06-30 | $2.07B | $0.13B | 6.27% |
| 2002-03-31 | $2.11B | $0.12B | 5.70% |
| 2001-12-31 | $2.19B | $0.13B | 6.08% |
| 2001-09-30 | $2.21B | $0.31B | 14.10% |
| 2001-06-30 | $2.24B | $0.39B | 17.55% |
| 2001-03-31 | $2.28B | $0.43B | 19.02% |
| 2000-12-31 | $2.28B | $0.45B | 19.73% |
| 2000-09-30 | $2.36B | $1.67B | 70.84% |
| 2000-06-30 | $2.44B | $1.22B | 50.08% |
| 2000-03-31 | $2.49B | $0.78B | 31.46% |
| 1999-12-31 | $2.47B | $0.36B | 14.65% |
| 1999-09-30 | $2.36B | $-1.35B | -57.26% |
| 1999-06-30 | $2.71B | $-0.90B | -33.11% |
| 1999-03-31 | $3.03B | $-0.39B | -12.83% |
| 1998-12-31 | $3.41B | $0.08B | 2.43% |
| 1998-09-30 | $3.88B | $0.57B | 14.69% |
| 1998-06-30 | $3.81B | $0.65B | 17.10% |
| 1998-03-31 | $3.74B | $0.60B | 16.07% |
| 1997-12-31 | $3.56B | $0.54B | 15.26% |
| 1997-09-30 | $3.34B | $0.58B | 17.20% |
| 1997-06-30 | $3.17B | $0.44B | 13.71% |
| 1997-03-31 | $3.04B | $0.40B | 13.07% |
| 1996-12-31 | $2.92B | $0.38B | 13.07% |
| 1996-09-30 | $2.75B | $0.27B | 9.78% |
| 1996-06-30 | $2.58B | $0.26B | 10.03% |
| 1996-03-31 | $2.36B | $0.26B | 10.79% |
| 1995-12-31 | $2.21B | $0.25B | 11.19% |
| 1995-09-30 | $2.01B | $0.15B | 7.46% |
| 1995-06-30 | $1.89B | $0.17B | 8.90% |
| 1995-03-31 | $1.79B | $0.19B | 10.41% |
| 1994-12-31 | $1.69B | $0.21B | 12.35% |
| 1994-09-30 | $1.60B | $0.27B | 16.91% |
| 1994-06-30 | $1.47B | $0.22B | 15.25% |
| 1994-03-31 | $1.34B | $0.17B | 12.84% |
| 1993-12-31 | $1.25B | $0.12B | 9.93% |
| 1993-09-30 | $1.20B | $0.11B | 8.73% |
| 1993-06-30 | $1.13B | $0.09B | 7.89% |
| 1993-03-31 | $1.04B | $0.08B | 7.90% |
| 1992-12-31 | $0.95B | $0.07B | 7.27% |
| 1992-09-30 | $0.89B | $0.06B | 7.23% |
| 1992-06-30 | $0.83B | $0.05B | 5.88% |
| 1992-03-31 | $0.82B | $0.04B | 5.01% |
| 1991-12-31 | $0.81B | $0.04B | 5.09% |
| 1991-09-30 | $0.82B | $0.05B | 6.21% |
| 1991-06-30 | $0.81B | $0.06B | 6.91% |
| 1991-03-31 | $0.78B | $0.04B | 5.39% |
| 1990-12-31 | $0.72B | $0.04B | 5.42% |
| 1990-09-30 | $0.69B | $-0.02B | -2.18% |
| 1990-06-30 | $0.64B | $-0.03B | -3.91% |
| 1990-03-31 | $0.62B | $-0.02B | -3.88% |
| 1989-12-31 | $0.62B | $-0.02B | -3.69% |
| 1989-09-30 | $0.61B | $-0.02B | -2.64% |
| 1989-06-30 | $0.60B | $-0.02B | -2.84% |
| 1989-03-31 | $0.57B | $-0.01B | -2.46% |
| 1988-12-31 | $0.54B | $-0.02B | -3.36% |
| 1988-09-30 | $0.45B | $0.02B | 3.60% |
| 1988-06-30 | $0.42B | $0.01B | 1.69% |
| 1988-03-31 | $0.39B | $0.01B | 1.78% |
| 1987-12-31 | $0.38B | $0.01B | 2.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $189.665B | $44.556B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |